Skip to main content
Shuttle Pharmaceuticals Holdings, Inc. logo

Shuttle Pharmaceuticals Holdings, Inc. — Investor Relations & Filings

Ticker · SHPH ISIN · US8256933024 US Manufacturing
Open in API
Filings indexed 266 across all filing types
Latest filing 2023-01-27 Regulatory Filings
Country US United States of America
Listing US SHPH

About Shuttle Pharmaceuticals Holdings, Inc.

https://shuttlepharma.com/

Shuttle Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on developing novel therapies to improve outcomes for cancer patients. The company's mission is to enhance the effectiveness of radiation therapy (RT) by developing drugs that sensitize cancer cells to radiation while protecting adjacent healthy tissues, thereby increasing cure rates and improving quality of life. Its lead product candidate, Ropidoxuridine, is an orally available radiation sensitizer in Phase II clinical development. The pipeline also includes a portfolio of preclinical selective histone deacetylase (HDAC) inhibitors. Additionally, Shuttle is developing diagnostic technologies, including a pretreatment blood test for prostate cancer patients to help predict treatment success and inform therapeutic decisions.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2023
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the SEC regarding a Registration Statement on Form S-1. It specifically states the withdrawal of a request for acceleration of the effective date of the Registration Statement. The content is correspondence related to regulatory filing procedures and does not contain financial data, report content, or presentation materials. The document is short (1433 characters) and serves as a formal communication about a regulatory filing process rather than the filing itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other specific categories.
2023-01-27 English
Regulatory Filings 2023
Regulatory Filings
2023-01-27 English
Regulatory Filings 2023
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content specifically mentions an announcement about the CEO presenting at an investor conference and furnishing a press release as an exhibit. There are no financial statements or detailed financial data included. The document is relatively short (3426 characters) and primarily serves as an announcement of an event rather than a detailed financial or management report. Therefore, it does not fit categories like Annual Report, Earnings Release, or Management Reports. It is best classified under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2023-01-26 English
Capital/Financing Update 2023
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-1. It references the Securities Act of 1933 and the registration process for securities offerings. The content is a formal request related to a capital raising filing, specifically a Form S-1 registration statement, which is used for initial public offerings or other securities registrations. There is no financial data or report content, only a procedural request regarding the registration statement's effective date. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2023-01-26 English
Capital/Financing Update 2023
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering, typically for an IPO or secondary offering. It includes a preliminary prospectus with detailed information about the company, the securities being offered, risk factors, management discussion, and other disclosures. This is not an annual report, earnings release, or any other financial report but a capital markets filing related to financing and securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is a full registration statement, not a brief announcement or a report publication notice.
2023-01-25 English
Regulatory Filings 2023
Regulatory Filings
2023-01-20 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.